No Data
While Institutions Own 25% of Cardiff Oncology, Inc. (NASDAQ:CRDF), Retail Investors Are Its Largest Shareholders With 57% Ownership
James Levine Bought 13% More Shares In Cardiff Oncology
Craig-Hallum Maintains Cardiff Oncology(CRDF.US) With Buy Rating, Announces Target Price $10
Piper Sandler Maintains Overweight on Cardiff Oncology, Raises Price Target to $10
Cardiff Oncology Analyst Ratings
Piper Sandler Maintains Cardiff Oncology(CRDF.US) With Buy Rating, Raises Target Price to $10